Response by Norgine Pharmaceuticals: re alleged advocacy campaign by IPASA opposing South Africa’s efforts to introduce intellectual property reforms aimed at increasing access to essential medicine

Read the full post here

This is a response from the following companies: Norgine Pharmaceuticals